Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
fetuin-A Double Nickase Plasmid (h): sc-401125-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- fetuin-A Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- fetuin-A Double Nickase Plasmid (h) and fetuin-A Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting AHSG. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: fetuin-A Antibody (H-4): sc-133146
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
fetuin-A Double Nickase Plasmid (h) | sc-401125-NIC | 20 µg | $410.00 | |||
fetuin-A Double Nickase Plasmid (h2) | sc-401125-NIC-2 | 20 µg | $410.00 |
AHSG encodes the human plasma glycoprotein fetuin-A, a hepatocyte-derived secreted factor that circulates at high abundance and binds calcium and phosphate complexes to modulate extracellular mineral homeostasis. Fetuin-A participates in regulation of calcification by forming calciprotein particles and influencing osteogenic signaling, and it can interact with multiple ligands to affect inflammatory and metabolic pathways. In cellular systems, altered AHSG expression or fetuin-A availability has been associated with changes in insulin signaling, adipocyte function, and macrophage activation states. Dysregulation of fetuin-A has been studied in contexts including ectopic calcification, metabolic syndrome-associated phenotypes, chronic inflammation, and kidney- and vascular-related pathobiology, supporting its use as a mechanistic marker in translational research models.
fetuin-A Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the AHSG locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within AHSG. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt AHSG function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of AHSG-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.